KIN240 Notes: Healthy Aging and Major Disease States (Flashcards)

Healthy Aging: Overview

• Healthy aging defined as the process of developing and maintaining the functional ability (health) that enables wellbeing in older age (World Health Organization).
• Key contrast: Healthy aging vs usual aging vs pathological aging.
• Healthy aging perspective: health reflects homeostasis between demands placed on an individual and their ability to respond; functional demands and responses diminish proportionally as aging progresses.
• Usual aging: trajectory with normal age-related changes plus some detriments in functional abilities, yet free of disease; diminished capacity beyond healthy aging but not disease-driven degradation.
• Pathological aging: trajectory with additional disease states and dysfunctions leading to more progressive deterioration in functional ability and wellbeing, occurring well before physiological system failure/death.
• Figure concept: Trajectories of Aging illustrate distinct paths from healthy to usual to pathological aging; health and wellbeing can be retained even as mortality approaches, but diminished health may precede death in pathological aging.
• Variation in aging: substantial inter-individual variation in retained health near lifespan limits; explained by system-level trajectories and genetic predispositions.
• Core idea: aging trajectories can be modified through optimization and compensation processes across the life course (lifestyle changes can shift toward healthier aging).
• Practical takeaway: altering lifestyle behaviors (e.g., physical activity, nutrition) can produce systemic changes that reduce disease risk, enhance function, and promote more optimal aging trajectories.
• Broad policy context: Healthy People initiative seeks cross-disciplinary evidence and recommendations; critique that it can be hard to identify the most relevant factors for health and wellbeing.
• Foundational concepts linking health to other outcomes: health/wellbeing is separable from mortality; improvements in health can occur even if mortality risk is not fully eliminated.
• Real-world relevance: understanding these trajectories informs public health, clinical prevention, and personal health decisions across the lifespan.
• Relevance to kinesiology: focus on major disease states and prevention strategies that preserve functional ability and wellbeing in aging populations.

Major Concepts and Mechanisms

• Homeostasis and demands: health is a balance between demands and the body's ability to respond; aging changes can alter both sides of the equation.
• Trajectories and genetics: a small amount of dysfunction in few systems may keep someone nearer healthy aging; widespread dysfunction across many systems pushes toward pathological aging.
• Prevention ladder: primary prevention (prevent onset), secondary prevention (screening and early detection), tertiary prevention (reduce progression and complications).
• Reserve Theory (bone and muscle): reserve (pre-disease capacity) buffers against disease impacts; higher reserve delays clinical expression of disease, lower reserve accelerates decline.
• Trajectory architecture: bones adapt to forces along existing load paths; mechanical loading guides bone modeling/remodeling to optimize strength and flexibility.

Coronary Heart Disease (CHD) and Related Concepts

• CHD definition: arterial disease due to atheroma buildup in the coronary arteries, leading to reduced or blocked blood flow to the heart; ischemic heart disease as a subtype.
• Epidemiology and impact:
  • Heart disease has been the leading cause of death in the US for about a century, accounting for roughly $30\%$ of deaths.
  • According to CDC: about $1$ person dies every $33$ seconds from heart disease; prevalence is about $20\%$ in adults aged $65$ and older.
  • In men, about half of sudden deaths from CHD occur without prior symptoms.
• Pathophysiology: atheroma formation leads to atherosclerosis and obstructed coronary flow.
• Symptoms: chest/shoulder/neck pain or pressure, fatigue, shortness of breath, irregular or rapid heartbeat, poor peripheral perfusion.
• Myocardial Infarction (MI): many individuals first present with MI as the initial clinical sign.
• Prevention and treatment:
  • Secondary prevention: screening to identify at-risk individuals using Life’s Essential 8; early follow-up and management.
  • Tertiary prevention for CHD: angioplasty with balloons and stents, plus blood-thinning medications; more severe cases may require CABG (coronary artery bypass grafting; often humorously referred to as "cabbage").
• Risk factors and comorbidity overlap:
  • Common risk factors include high cholesterol, hypertension, diabetes, male sex, older age, poor diet, smoking, and physical inactivity.
  • Overlap with other conditions underscores the need for integrated prevention strategies.
• Prevention framework:
  • Primary prevention: physical activity is a key predictor of risk reduction; small daily activity (e.g., 10 minutes per day total, ~70 minutes per week) substantially lowers risk.
  • Quantified benefit: accumulating only $70\text{ minutes/week}$ of activity (any intensity above very light) is associated with roughly a $54\%$ reduction in risk of developing heart disease.
  • Mechanistic pathways for physical activity:
  • Vasodilation and angiogenesis: increases in blood vessel diameter, capillary growth, and vascular remodeling, improving blood flow and oxygen delivery.
  • Mitochondrial biogenesis: increased renewal/regeneration of mitochondria in fat, skeletal muscle, and cardiac muscle to boost energy production and function.
  • Anti-inflammatory effects: creates conditions favorable to cellular repair and reduces inflammatory damage to cardiac tissue.

Chronic Obstructive Pulmonary Disease (COPD)

• Definition: a chronic inflammatory lung disease characterized by airflow limitation and reduced gas exchange; encompasses emphysema and chronic bronchitis; major cause of death globally (3rd leading cause).
• Emphysema: destruction of alveoli due to smoke/irritants, reducing gas exchange surface area.
• Chronic bronchitis: chronic inflammation of bronchial tubes narrowing airways and impairing ventilation.
• Symptoms: shortness of breath, wheezing, chest tightness, chronic cough, fatigue.
• Disease progression and diagnosis: symptoms often appear after substantial lung damage; many cases go undiagnosed or untreated (estimates around $50\%$ of COPD deaths).
• Stages of COPD (airflow impairment):
  • Stage 1 (Mild): airflow at 80\% of normal; possible shortness of breath with moderate exertion.
  • Stage 2 (Moderate): airflow 50–79\% of normal; frequent coughing/wheezing/SOB.
  • Stage 3 (Severe): airflow 30–50\% of normal; hospital/clinical treatment necessary to manage symptoms.
  • Stage 4 (Very Severe): airflow < 30\% of normal; persistent symptoms; potential life-threatening exacerbations.
• Comorbidities and risk factors:
  • Common comorbidities include heart disease, diabetes, high cholesterol, and hypertension.
  • Asthma frequently co-occurs with COPD (historical view vs broader COPD definitions include chronic asthma).
• Prevention and management:
  • Tertiary prevention largely relies on pulmonary medications and respiratory therapy; many patients require ongoing supplemental oxygen.
  • Secondary prevention focuses on screening for tobacco exposure, occupational exposures, and history of respiratory infections.
• Physical activity and COPD:
  • The relationship is bidirectional: higher aerobic fitness improves metabolic and respiratory efficiency, while significant COPD symptoms can dampen activity.
  • Evidence suggests low activity correlates with greater COPD severity, but causality is complex—reduced activity may be a symptom rather than a cause.
  • Short bouts of light activity (e.g., a brief walk) can temporarily reduce symptoms, suggesting potential tertiary-use opportunities, though not ideal for diagnosis.
  • Overall aim: improve aerobic capacity to enhance respiratory and metabolic function, reducing exogenous factor–induced deterioration.

Osteoporosis and Bone Health

• Osteoporosis vs osteopenia definitions:
  • Osteoporosis: bone mineral density (BMD) below a t-score of $-2.5$.
  • Osteopenia: BMD between $-1.0$ and $-2.5$.
  • Diagnosis via dual-energy X-ray absorptiometry (DEXA).
• Prevalence and sex differences:
  • In the US, about $54\%$ of postmenopausal women are osteopenic; an additional $30\%$ are osteoporotic; females have roughly fourfold higher prevalence than males.
• Bone remodeling physiology:
  • Normal bone remodeling balances bone resorption by osteoclasts with bone formation by osteoblasts.
  • In osteoporosis/osteopenia, remodeling is dysregulated, with increased resorption and decreased formation, reducing bone mineral density.
• Clinical implications:
  • Osteoporosis increases fracture risk and prolongs healing time due to slowed osteoblast activity.
  • Osteoporosis is typically asymptomatic until fractures occur.
• Prevention and treatment framework:
  • Tertiary prevention focuses on slowing bone density loss with pharmacological agents and on rehabilitation to reduce fall risk (fall-proofing living environments).
  • Secondary prevention includes regular DEXA scans for individuals over age 40 (often covered by insurance every 2 years).
• Risk factors and prevention spectrum:
  • Fixed vs modifiable risk factors: female sex, small body frame, family history, low early-life calcium, tobacco use, history of disordered eating all predispose to lower baseline BMD and higher osteoporosis risk.
  • Primary prevention mechanism: physical activity influences bone density by mechanical loading; bones adapt to loads through modeling/remodeling.
• Bone modeling and the Theory of Trajectory Architecture:
  • Bone modeling reshapes bone to optimize strength along force transmission paths.
  • Mechanical loading from activity drives osteoclast-mediated resorption of poorly aligned bone and osteoblast-driven formation along force paths, increasing BMD.
• Reserve Theory of bone density:
  • Higher pre-disease bone density (reserve) delays onset of clinically significant osteoporosis when disease processes occur; low reserve accelerates functional decline.
  • Visuals referenced: Reserve Theory of Bone Density.
• Peak bone density and timing:
  • Peak BMD typically occurs between $20$ and $25$ years of age.
  • Mechanical loading is most effective before puberty; effectiveness declines between ages 11–19 and is greatly reduced afterward.
  • Prevention emphasis: Primordial (before puberty) loading yields the strongest benefits; primary prevention may still yield benefits later, albeit less.
• Time course and loading limits:
  • Remodeling benefits from mechanical loading may take $4\text{ to }6\text{ months}$ to manifest.
  • Excessive mechanical loading (> $130\%$ of typical weekly workload) raises injury risk; injury risk rises to $15\%$ at $200\%$ weekly workload.
• Mechanosignaling and saturation:
  • The cellular signaling cascade responsible for mechanosensitivity can become “blind” after a few hundred exposures, with a recovery window of $3\text{ to }4\text{ hours}$.
  • A runner with higher weekly mileage may not gain additional bone modeling benefits and may risk bone density loss if the workload is disproportionately increased.
• Practical implications for prevention: maintaining appropriate, regular mechanical loading through activity supports bone density and reduces osteoporosis risk; overtraining can be counterproductive.

Sarcopenia: Muscle Health in Aging

• Definition: a muscle disease characterized by loss of muscle mass and strength; not always explicitly named in all health initiatives but critically linked to health and disease burden in aging.
• Classical vs modern view:
  • Classical view: a normal aging process with progressive muscle loss.
  • Modern view: sarcopenia is a distinct dysregulation that leads to abnormally severe muscle degeneration.
• Age-related trajectory:
  • Ages 30–50: approximate 3–10\% reduction in muscle fiber mass.
  • Ages 60–80: about 15\% reduction per decade.
  • After age 80: about 30\% reduction per decade.
• Diagnostic and screening considerations (ICD codification in 2016):
  • Proposed screening metrics include walking speed, hand grip strength, need for assistive devices, and thermoregulation needs (sleep/warmth devices).
  • Prevalence estimates: as many as $10\to 20\%$ of individuals over age $50$ meet criteria for clinically significant sarcopenia; up to $90\%$ of affected individuals are not actively seeking treatment.
  • In long-term rehab units, prevalence exceeds $50\%$.
• Comorbidities:
  • Strong associations with heart disease, COPD, diabetes, and osteoporosis.
• Prevention and treatment spectrum:
  • Tertiary prevention emphasizes physical and occupational therapy to maintain muscle function, coupled with nutrition to address protein insufficiency.
  • Pharmacological interventions (e.g., low-dose steroids) have shown some promise in slowing muscle wasting; various clinical trials ongoing targeting underlying mechanisms.
  • Primary prevention is most evident and direct: resistance training to increase muscle mass, strength, and endurance improves function and reduces fall risk, supports bones, and enhances thermoregulation.
• Reserve Theory and muscle mass:
  • Similar to bones, higher muscle reserve buffers against functional decline; greater muscle mass supports better health outcomes and reduced fall risk.

Mechanistic Concepts: Integration Across Systems

• Mechanisms contributing to healthy aging include:
  • Vasodilation and angiogenesis (vascular remodeling) to improve oxygen delivery and reduce vascular stress.
  • Mitochondrial biogenesis to enhance cellular energy production in muscle, fat, and cardiac tissue.
  • Anti-inflammatory pathways that support tissue repair and limit inflammatory damage.
• Conceptual framework: Trajectory Architecture (bone) and reserve concepts (bone and muscle) explain why some individuals maintain function longer even with aging, while others decline more rapidly.
• Importance of early life and loading patterns:
  • Primordial prevention via early mechanical loading yields the strongest benefits for bone density maintenance.
  • Hormonal and nutritional factors across life influence peak reserves and subsequent aging trajectories.

Prevention Frameworks and Public Health Context

• Prevention types:
  • Primary prevention: maintaining regular physical activity and healthy lifestyle to prevent disease onset.
  • Secondary prevention: screening (e.g., Life’s Essential 8 for heart disease) to identify and follow up individuals at risk.
  • Tertiary prevention: rehabilitation and interventions to slow progression and reduce complications after disease onset.
• Life’s Essential 8 (AHA guideline mentioned):
  • Four behaviors: nutrition, physical activity, tobacco use, sleep.
  • Four factors: obesity, blood sugar, blood pressure, cholesterol.
• Practical implications for aging populations:
  • Regular activity, strength training, and weight-bearing exercises support bone and muscle health.
  • Smoking cessation, blood pressure and cholesterol management, and diabetes control reduce cardiovascular risk.
  • Screening and preventive care (DEXA, metabolic screening) enable early intervention.

Summary of Key Statistics and Facts (LaTeX-formatted)

• Death and prevalence data:
  • Heart disease mortality share: $<br /> oughly 30\%$ of deaths.
  • Deaths due to heart disease: $1$ person every $33\text{ seconds}$.
  • Heart disease prevalence in adults ≥$65$: $20\%$.
• Prevention impact:
  • Physical activity primary prevention impact: $70\text{ minutes/week}$ reduces heart disease risk by about $54\%$.
• COPD staging and airflow:
  • Stage 1: $80\%$ normal airflow; Stage 2: $50\%\text{ to }79\%$; Stage 3: $30\%\text{ to }50\%$; Stage 4: <30\%.
• Osteoporosis thresholds:
  • Osteoporosis: ext{BMD} ext{ t-score}<-2.5; Osteopenia: -2.5\le ext{t-score}<-1.0 (approximate ranges as defined by WHO).
• Peak bone density timing: $20\text{ to }25\text{ years}$.
• Mechanical loading time to observe bone density changes: $4\text{ to }6\text{ months}$.
• Injury risk with loading: from $5\%$ at $130\%$ workload to $15\%$ at $200\%$ workload.
• Sarcopenia prevalence indicators: 10\%\to\20\% over age $50$; up to $90\%$ not seeking treatment; >$50\%$ in long-term rehab.

Connections to Foundational Principles and Real-World Relevance

• The aging framework integrates physiology (cardiovascular, respiratory, bone, muscle systems) with public health strategies and preventive medicine.
• It emphasizes that aging is not uniform and that interventions can shift trajectories toward healthier aging.
• The material highlights the importance of early, sustained physical activity across the lifespan to build reserves and support functional health in old age.
• Ethical/practical considerations include access to screening (DEXA), affordability of cardiovascular and respiratory therapies, and equitable delivery of preventive services across populations.

Potential Exam Focus Points

• Distinguish healthy aging, usual aging, and pathological aging with definitions and trajectories.
• Explain the Reserve Theory for bone density and for muscle mass, and how it affects aging trajectories.
• Describe CHD/CHF pathophysiology, major risk factors, and primary/secondary/tertiary prevention approaches.
• Define COPD, its components (emphysema, chronic bronchitis), stages, and the role of physical activity in management and prevention.
• Define osteoporosis and osteopenia, explain bone remodeling, and discuss prevention strategies (primordial vs primary vs secondary vs tertiary).
• Understand the dual role of physical activity in disease prevention and potential symptom exacerbation in COPD, and the mechanistic pathways linking activity to health outcomes.
• Recall key statistics and their implications for public health and clinical practice (e.g., Life’s Essential 8, minutes of activity, screening intervals).

References and Suggested Readings (as cited in notes)

• Stones, M. J., Kozma, A., & Hannah, T. E. (1990). The measurement of individual differences in aging: The distinction between usual and successful aging. In Cognitive and behavioral performance factors in atypical aging (pp. 181-218). New York, NY: Springer New York.
• Institute of Medicine (US). (2011). A nationwide framework for surveillance of cardiovascular and chronic lung diseases. Washington, DC: National Academies Press.
• Föger–Samwald, U., et al. (2020). Osteoporosis: Pathophysiology and therapeutic options. EXCLI journal, 19, 1017. https://doi.org/10.17179/excli2020-2591